• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB, INC 25G POSTERIOR X PACK WITH V&AFI&WF; UNIT, PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB, INC 25G POSTERIOR X PACK WITH V&AFI&WF; UNIT, PHACOFRAGMENTATION Back to Search Results
Model Number BL5425WVX
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problem Endophthalmitis (1835)
Event Date 08/10/2022
Event Type  Injury  
Event Description
A user facility in japan reported that three cases of post-op endophthalmitis on three patients.A pack was discontinued in japan, and the surgeon switched to a different part number.After the switch to this pack, they noticed that two cases happened.The surgeon put an additional filter into the pressurization route as the perfusion process changed from spontaneous drip to pressurized perfusion with the new pack.Bss was also changed from a soft pack product to a glass bottle product.At the time, the surgeon considered that the issue was not caused by the disposable pack, and thought the bss was the cause.Patients are in remission after being given typical eyedrops, and are no longer under treatment.There was no decreased visual acuity, and no hospitalization was required.This report is on the first case only.
 
Manufacturer Narrative
The device was discarded by the user.Manufacturing and sterilization records were reviewed and found to be acceptable.The investigation is underway.See related 0001920664-2022-00116 and 0001920664-2022-00125.
 
Manufacturer Narrative
The product was discarded and is reported as not available.Unable to investigate further for root cause which is unknown.A review of the monthly bioburden results for the six months surrounding the manufacture of this product on 12-10-2021 shows all bioburden values were within acceptable parameters.The lot history, trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.No corrective action required.The investigation is complete.See related 0001920664-2022-00116 and 0001920664-2022-00125.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
25G POSTERIOR X PACK WITH V&AFI&WF
Type of Device
UNIT, PHACOFRAGMENTATION
Manufacturer (Section D)
BAUSCH + LOMB, INC
1400 n. goodman st.
rochester NY 14609
Manufacturer (Section G)
BAUSCH + LOMB, INC
3365 tree court industrial blv
st. louis MO 63122
Manufacturer Contact
juli moore
3365 tree court industrial blv
saint louis, MO 63122
636226-322
MDR Report Key15374823
MDR Text Key299448400
Report Number0001920664-2022-00124
Device Sequence Number1
Product Code HQC
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K063331
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 08/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/01/2023
Device Model NumberBL5425WVX
Device Lot NumberX0768
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/07/2022
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received10/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BSS
Patient Outcome(s) Other;
-
-